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Purpose: Angiogenesis is implicated as a cause of many diseases as well
as an inevitable repair process. In osteoarthritic (OA) knees, pathological
changes in the subchondral bone are considered to be related to disease
initiation, progression, and a potent source of knee pain. Previous studies
indicated that angiogenesis at the osteochondral junction might facilitate
the progression of OA. Despite the presence of vascular invasion into
the cartilage from the subchondral bone in end-stage OA knees, it is
largely unknown when vascular invasion occurs. Since vascular invasion
depends on the angiogenic activities of tissue, we hypothesized that there
might be a speciﬁc period with elevated angiogenic activities during the
development of OA.
The purpose of this study was to investigate the change of angiogenic
activities during the development of OA by biochemically and
histochemically in rabbit OA model.
Methods: OA was surgically induced by anterior cruciate ligament
transection (ACLT) in left knee of 12 months old female New Zealand
white rabbits. Contra lateral knees were sham operated. Animals were
necropsied at 2, 4, 6, 8, and 12 weeks postsurgery. Six animals were
allocated each time point. All the knees were examined macroscopically
and three rabbits for histological evaluation and three were for
angiogenic activity analysis. Histologic evaluation was performed with
hematoxylin and eosin, safranin-O staining.OA changes were evaluated
by the grading score of OARSI.
For angiogenic activity analysis subchondral bone and cartilage of the
medial femoral condyle (MFC) and those of lateral femoral condyle (LFC)
were obtained from each knee at each time point. The specimens were
co-cultured with human umblical vein endothelial cell (HUVEC) and
ﬁbroblasts using Angiogenesis Kit (KURABO, Osaka, Japan) for 11 days
according to the manufacturer’s instruction. After formation of the vessel
lumens were identiﬁed, the vessels were immunostained with anti-CD31
antibodies and four parameters concerning angiogenic activities, i.e. the
length, area, number of joints and paths of newly created vessels, were
analyzed automatically by Angiogenesis Image Analyzer (KURABO, Osaka,
Japan). To correct age and tissue speciﬁc angiogenic activities, each
parameter of OA knees was divided by corresponding sham operated
knees.
Results: The characteristic OA features were detected from 4 weeks in
MFC, and from 6weeks in LFC macroscopically and microscopically and
the grading score of OARSI increased time dependently.
The calculated parameters of the angiogenesis at subchondral bone of
MFC and LFC increased time dependently in the early period, however
it decreased at the later period. Angiogenic activities of MFC started
to increase at 4 weeks and increased to the peak at 6weeks. After the
peak, it took downward turn at 8weeks and decreased until 12weeks.
Those of LFC took the same tendency and started to increase at 6 weeks,
but started to decrease at 8weeks. On the other hand, the angiogenic
activity of cartilage had no changes during study period. This suggested
angiogenic activities of subchondral bone increased in the early to
moderate phase of OA when cartilage had been degenerated, and activity
decreased in the severe OA when cartilage had been lost.
Conclusions: Several previous studies reported that invasion of vascular
tissue from the subchondral bone into the cartilage was related with
degeneration of articular cartilage. This study indicated that the peak
of the angiogenic activities of subchondral bone was in the early stage
of OA and presumably followed by the invasion of vascular tissue into
the cartilage. This result might implicate new OA treatment in terms of
angiogenesis.
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Purpose: To examine the effect of the chondrocyte-derived extracellular
matrix (CD-ECM) on the vessel formation in vitro and in a nude mice
model.
Method: Human umbilical vein endothelial cells (HUVECs) were plated
on a bio-membrane made of CD-ECM or human amniotic membrane
(HAM) in vitro. The adhesion, proliferation and tube formation activity
of HUVECs were examined. Then, the CD-ECM and HAM powders were
mixed individually in Matrigel and injected subcutaneously into nude
mice in vivo. The vessel invasion into the Matrigel was examined after
1 week.
Results: The adhesion and proliferation of HUVECs were more efﬁcient
on the HAM membrane than on the CD-ECM membrane. The endothelial
cells exposed to HAM membrane had signiﬁcant increase in growth
compared to the CD-ECM membrane at all experiment period (Fig. 1a).
Fig. 1. Inﬂuence of the chondrocyte-derived ECM (CD-ECM) on the cell
adhesion, proliferation and tube-forming ability of human umbilical
vein endothelial cells (HUVECs). (a) Cell adhesion and proliferation on
membranes made of CD-ECM and human amniotic membrance (HAM).
(b) Tube formation assay on basement membrane matrix/CD-ECM and
HAM powder.
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